Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVERS.L Regulatory News (VERS)

  • There is currently no data for VERS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

8 Sep 2016 07:00

RNS Number : 2542J
Verseon Corporation
08 September 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Verseon Corporation

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation:

Woodford Investment Management LLP ("Woodford")

4. Full name of shareholder(s) (if different from 3.):

Clients of Woodford

5. Date of the transaction and date onwhich the threshold is crossed orreached:

06.09.16

6. Date on which issuer notified:

07.09.16

7. Threshold(s) that is/are crossed orreached:

16%

     
 

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

USU9221J1098

24,065,011

 24,065,011

 

24,335,011

24,335,011

 

16.08%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

24,335,011

16.08%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Woodford, as Investment Manager

 

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will ceaseto hold:

 

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

 

14. Contact name:

Akpene Akonou

15. Contact telephone number:

01865 809024

   

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFDLLBQKFXBBE
Date   Source Headline
18th Dec 20194:40 pmRNSSecond Price Monitoring Extn
18th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Dec 20198:18 amRNSTender Offer Results & Special Meeting Notice
9th Dec 20197:00 amRNSResult of Special Shareholder Meeting
29th Nov 20199:05 amRNSSecond Price Monitoring Extn
29th Nov 20199:00 amRNSPrice Monitoring Extension
26th Nov 20192:05 pmRNSSecond Price Monitoring Extn
26th Nov 20192:00 pmRNSPrice Monitoring Extension
26th Nov 20197:00 amRNSCancellation of Depositary Interests Facility
25th Nov 20193:02 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSHolding(s) in Company
22nd Nov 201911:23 amRNSUpdate on Tender Offer
21st Nov 20194:40 pmRNSSecond Price Monitoring Extn
21st Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20194:33 pmRNSTransaction in Own Shares
20th Nov 20198:33 amRNSIssue of Debt
20th Nov 20197:30 amRNSProposed Cancellation of Admission to AIM
29th Oct 20197:00 amRNSResult of 2019 AGM
24th Oct 20199:43 amRNSUpdate on Facility Sale-Leaseback
23rd Oct 201911:28 amRNSSale-Leaseback of Verseon's Facility
18th Oct 20193:38 pmRNSAnnouncement of 2019 Annual General Meeting
17th Oct 20196:24 pmRNSHolding(s) in Company
16th Oct 20195:24 pmRNSHolding(s) in Company
30th Sep 20197:00 amRNSInterim Results
1st Aug 20194:40 pmRNSSecond Price Monitoring Extn
1st Aug 20194:35 pmRNSPrice Monitoring Extension
1st Aug 20192:05 pmRNSSecond Price Monitoring Extn
1st Aug 20192:00 pmRNSPrice Monitoring Extension
11th Jul 20193:43 pmRNSHolding(s) in Company
3rd Jul 20197:00 amRNSAdditional Listing & Total Voting Rights
28th Jun 20197:00 amRNSFinal Results
25th Jun 20197:00 amRNSAdditional Listing & Total Voting Rights
4th Jun 20197:00 amRNSVerseon showcases oral DME candidates at BIO 2019
30th Apr 20197:00 amRNSVerseon presents DME candidate at ARVO 2019
4th Apr 20197:00 amRNSAdditional Listing & Total Voting Rights
1st Apr 20194:10 pmRNSNew TIDM and ISIN for Subscription Shares
28th Mar 20197:00 amRNSFurther Update to Admission of Subscription Shares
22nd Mar 20197:00 amRNSUpdate to Admission of Subscription Shares
19th Mar 20197:00 amRNSResult of Subscription & Related Party Transaction
18th Mar 20197:00 amRNSVerseon announces security token offering
15th Mar 201912:00 pmRNSChange of TIDM
4th Mar 20197:00 amRNSAdditional Listing & Total Voting Rights
11th Feb 20197:00 amRNSVerseon presents low bleed PROACs at ISC 2019
4th Feb 20197:00 amRNSFirst participant dosed in Verseon clinical trial
29th Jan 20197:00 amRNSDirectorate Change
8th Jan 201912:00 pmRNSAdditional listing confirmation
3rd Jan 201910:20 amRNSAdditional Listing & Total Voting Rights
27th Dec 20187:00 amRNSAdditional Listing and Total Voting Rights
6th Nov 20187:00 amRNSResult of AGM and changes to the Board
5th Nov 20187:00 amRNSAdditional Listing & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.